Jaap StuutChief Executive Officer
Jaap has been with the Company since 2013 and was previously responsible for the global marketing and corporate development of the Company, as well as having the direct sales responsibility for the USA and Brazil. Prior to this, he was responsible for global marketing.
Before joining IDS, Jaap worked at SHO Centra for Medical Diagnostics where he held the position of Chief Operating Officer. He was responsible for Sales, Marketing and Operations. Additionally he worked at Roche Diagnostics where he held several senior Sales & Marketing roles in the Clinical Medical Diagnostics team. Jaap is a Dutch national and holds an MBA from Bradford University School of Management.
Mr Paul MartinFinance Director and Company Secretary
Paul joined IDS as Finance Director on 4 January 2016. Previously Paul was based in Singapore as CFO of Volex plc’s Power Division, a major manufacturer of electrical power cables with operations throughout Asia.
Paul qualified as a Chartered Accountant with Deloitte in 2002, and subsequently worked in a number of senior finance roles in the technology sector
Dr Burkhard WittekChairman
Dr Wittek holds an MBA from Harvard Business School. After working for Dresdner Bank AG he spent 13 years with The Boston Consulting Group where he was a senior partner with worldwide responsibility for the consumer goods retail and healthcare sectors.
In 1990 he founded FORUM Family Office GmbH, which makes long-term investments in German Private Equity and European Small and Midcap publicly quoted companies. The healthcare sector is a focus area of FORUM as well as companies undergoing transitions.
Mr Peter WilliamsonNon-executive Director
Peter joined IDS as Non-executive Director on 15th June 2015. Peter holds a Master of Business Administration from the University of Edinburgh. Between 1993 and 2010 worked in various positions for BTR Automotive, Metzeler, Trelleborg, Xerium Technologies and IBP Group in locations in Europe, USA and Asia. Since 1999 he has worked in businesses owned by private equity with Metzeler belonging to CVC and Xerium Technologies an Apax portfolio business. His final executive position was as Group CEO for IBP Group (a Sun Capital Partner portfolio business) and since then has worked as an operating partner for Better Capital and currently has a portfolio of Non-executive appointments.
Dr. Peter KasparNon-executive Director
Peter Kaspar has over 35 years experience in life sciences and diagnostics. From 2005 to 2011, he was a member of the Management Committee of bioMérieux S.A where he worked as Head of the Molecular Diagnostics unit, Head of Global Research & Development and Head of the Microbiology unit. Prior to bioMérieux, he spent a significant part of his career with Roche Diagnostics (formerly Boehringer Mannheim GmbH) in Europe, Latin America and the US, with responsibilities in strategy, business development and R&D management. He holds a PhD in biochemistry from the University of Muenster.